|
21 Companies |
|
15 Products |
|
15 Products |
|
14 Mechanisms of Action |
|
0 Trials |
|
73 News |
|
| «12 |
- Trial completion: Acupuncture for Sleep Disruption in Cancer Survivors (clinicaltrials.gov) - May 29, 2013
P=N/A, N=56, Completed, Sponsor: Stanford University
Active, not recruiting --> Completed
- New P2/3 trial: Treatment for Insomnia During Pregnancy (clinicaltrials.gov) - May 1, 2013
P2/3, N=0, Recruiting, Sponsor: Stanford University
- eszopiclone / Generic mfg.
Enrollment change: MVP#1: Mindfulness Versus Pharmacotherapy for Chronic Insomnia: A Pilot Study (clinicaltrials.gov) - Feb 19, 2013
P2/3, N=30, Completed, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Active, not recruiting --> Completed N=40 --> 30
- | New P1 trial: A Study of LY2624803 in Japanese Participants With Transient Insomnia (clinicaltrials.gov) - Feb 4, 2013
P1, N=24, Completed, Sponsor: Eli Lilly and Company
- | New P1 trial: A Study of LY2624803 in Participants With Transient Insomnia (clinicaltrials.gov) - Jan 28, 2013
P1, N=32, Completed, Sponsor: Eli Lilly and Company
- ||||| eszopiclone / Generic mfg.
Enrollment change: A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126) (clinicaltrials.gov) - Dec 27, 2012
P2/3, N=192, Completed, Sponsor: Eisai Co., Ltd.
N=40 --> 30 N=70 --> 192
- prazosin / Generic mfg.
Trial termination: Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder (clinicaltrials.gov) - Nov 25, 2012
P=N/A, N=20, Terminated, Sponsor: Seattle Institute for Biomedical and Clinical Research
N=70 --> 192 Completed --> Terminated; Insufficient Enrollment
- prazosin / Generic mfg.
Enrollment change: Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder (clinicaltrials.gov) - Nov 25, 2012
P=N/A, N=20, Terminated, Sponsor: Seattle Institute for Biomedical and Clinical Research
Completed --> Terminated; Insufficient Enrollment N=95 --> 20
- ||| Enrollment change: Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia (clinicaltrials.gov) - Nov 8, 2012
P2, N=112, Completed, Sponsor: Actelion
N=95 --> 20 N=80 --> 112
- | Enrollment closed: Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia (clinicaltrials.gov) - Oct 25, 2012
P2/3, N=111, Active, not recruiting, Sponsor: Duke University
N=80 --> 112 Recruiting --> Active, not recruiting
- Trial initiation date: Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms (clinicaltrials.gov) - Jul 8, 2012
P=N/A, N=90, Completed, Sponsor: University of California, Los Angeles
Recruiting --> Active, not recruiting Initiation date: Jan 2007 --> Mar 2008
- Trial completion: Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms (clinicaltrials.gov) - Jul 8, 2012
P=N/A, N=90, Completed, Sponsor: University of California, Los Angeles
Initiation date: Jan 2007 --> Mar 2008 Active, not recruiting --> Completed
- ||||||| Circadin (melatonin prolonged release) / Lundbeck, Neurim, Flynn Pharma, Grupo Insud, Biocodex, Kuhnil Pharma
Trial completion: Efficacy and Safety of KI1001 in ? 55 Years Old Insomnia Patients (clinicaltrials.gov) - Apr 22, 2012
P3, N=170, Completed, Sponsor: Kuhnil Pharmaceutical Co., Ltd.
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion: Examining the Effect of Acupuncture on Sleep Difficulties Related to Post Traumatic Stress Disorder (clinicaltrials.gov) - Apr 5, 2012
P=N/A, N=25, Completed, Sponsor: Department of Veterans Affairs
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Effects of Chronic Insomnia on the Neuroendocrine Regulation of Glucose and Lipid Metabolism (clinicaltrials.gov) - Mar 7, 2012
P0, N=25, Completed, Sponsor: University Hospital, Basel, Switzerland
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion: Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease (clinicaltrials.gov) - Jan 11, 2012
P=N/A, N=132, Completed, Sponsor: University of Washington
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Effectiveness of Internet Cognitive Behavioral Therapy Intervention for Treating Insomnia (clinicaltrials.gov) - Jan 10, 2012
P1/2, N=44, Completed, Sponsor: University of Virginia
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Belsomra (suvorexant) / Merck (MSD)
Trial completion: Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study A (MK-4305-028) (clinicaltrials.gov) - Jan 9, 2012
P3, N=1023, Completed, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||| piromelatine (Neu P11) / Neurim
New P2 trial: Sleep Laboratory Study to Investigate the Safety and Efficacy of Neu-P11 in Primary Insomnia Patients (clinicaltrials.gov) - Dec 8, 2011
P2, N=137, Completed, Sponsor: Neurim Pharmaceuticals Ltd.
- | Enrollment open: SHUTi: An Interactive Internet Intervention for Adults With Insomnia (clinicaltrials.gov) - Oct 10, 2011
P3, N=300, Recruiting, Sponsor: University of Virginia
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- |||||||||| Circadin (melatonin prolonged release) / Lundbeck, Neurim, Flynn Pharma, Grupo Insud, Biocodex, Kuhnil Pharma
New P3 trial: Efficacy and Safety of KI1001 in ? 55 Years Old Insomnia Patients (clinicaltrials.gov) - Oct 5, 2011
P3, N=170, Completed, Sponsor: Kuhnil Pharmaceutical Co., Ltd.
- ||| zolpidem ER / Generic mfg.
Enrollment change: A Study to Compare Efficacy and Safety of Zolpidem Modified Release Formulation Versus Zolpidem in Insomnia Patients (clinicaltrials.gov) - Oct 4, 2011
P4, N=132, Completed, Sponsor: Astellas Pharma Inc
Not yet recruiting --> Recruiting N=180 --> 132
- | Enrollment change: Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing (clinicaltrials.gov) - Oct 4, 2011
P4, N=20, Completed, Sponsor: University of Rochester
N=180 --> 132 N=44 --> 20
- |||| zolpidem ER / Generic mfg.
Trial completion: A Study to Compare Efficacy and Safety of Zolpidem Modified Release Formulation Versus Zolpidem in Insomnia Patients (clinicaltrials.gov) - Oct 4, 2011
P4, N=132, Completed, Sponsor: Astellas Pharma Inc
N=44 --> 20 Recruiting --> Completed
- | zolpidem ER / Generic mfg.
Trial completion: A Study to Evaluate Efficacy and Safety of Zolpidem Modified Release Formulation in Insomnia Patients (clinicaltrials.gov) - Oct 4, 2011
P4, N=42, Completed, Sponsor: Astellas Pharma Inc
Recruiting --> Completed Recruiting --> Completed
- |||| zaleplon / Generic mfg.
Trial completion: Study of Sleep-maintenance Activity of 3 Doses of SKP-1041 (clinicaltrials.gov) - Sep 25, 2011
P2, N=67, Completed, Sponsor: Somnus Therapeutics, Inc.
Recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: Examining the Effect of Acupuncture on Sleep Difficulties Related to Post Traumatic Stress Disorder (clinicaltrials.gov) - Sep 21, 2011
P=N/A, N=25, Completed, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Completed N=60 --> 25
- || New P3 trial: SHUTi: An Interactive Internet Intervention for Adults With Insomnia (clinicaltrials.gov) - Sep 19, 2011
P3, N=300, Recruiting, Sponsor: University of Virginia
- Enrollment closed: A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD) (clinicaltrials.gov) - Aug 9, 2011
P=N/A, N=76, Active, not recruiting, Sponsor: University of Arizona
N=60 --> 25 Recruiting --> Active, not recruiting